Inaktiver Wert

Andere Sprachen Oramed Pharmaceuticals, Inc. Xetra

Aktien

OJU

US68403P1049

OJU

Schlusskurs Xetra Andere Börsenplätze
- ^EUR	-

15.05.	Compugen ernennt David Silberman zum CFO	MT
13.05.	Oramed Pharmaceuticals Inc. gibt den Rücktritt von David Silberman als Schatzmeister und Sekretär mit Wirkung zum 12. Juli 2024 bekannt	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Compugen Names David Silberman CFO	15.05.
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024	13.05.
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	13.05.
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	13.05.
Oramed: Q1 Earnings Snapshot	10.05.
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06.05.
Oramed Pharmaceuticals : 13D-Nadav Kidron	26.03.
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19.03.
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19.03.
Oramed Pharmaceuticals : Other Report or Announcement	18.03.
Oramed Pharmaceuticals : Other Report or Announcement	18.03.
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06.03.
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19.01.
Oramed Pharmaceuticals : Other Report or Announcement	02.01.
Oramed Pharmaceuticals : Other Report or Announcement	24.12.
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19.12.
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	19.12.
Oramed: Q3 Earnings Snapshot	10.11.
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Oramed Pharmaceuticals, Inc. Xetra

Aktien

OJU

US68403P1049

OJU

Andere Sprachen

Filter